stockportfolio.pro
HealthEquity, Inc. P/E Ratio 2013–2026
HealthEquity, Inc. (HQY) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth -7.7%/yr over 13 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2026 | 34.83 | -65.6% |
| FY 2025 | 101.30 | -14.2% |
| FY 2024 | 118.09 | — |
| FY 2023 | — | — |
| FY 2022 | — | — |
| FY 2021 | 696.25 | +511.3% |
| FY 2020 | 113.90 | +113.8% |
| FY 2019 | 53.28 | -19.0% |
| FY 2018 | 65.74 | -37.5% |
| FY 2017 | 105.11 | +36.6% |
| FY 2016 | 76.96 | -22.2% |
| FY 2015 | 98.90 | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
Source: HealthEquity, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for HealthEquity, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHealthEquity, Inc. — frequently asked questions
What is HealthEquity, Inc.'s price-to-earnings ratio?
HealthEquity, Inc. (HQY) reported price-to-earnings ratio of 34.83 for fiscal year 2026, per its SEC filings.
How has HealthEquity, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2013 and 2026, HQY's price-to-earnings ratio declined at roughly 7.7% per year (compound annual rate), from 98.90 to 34.83.
Where does this data come from?
Figures are computed from HealthEquity, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.